EuroPCR 2021 - Innovations in chronic heart failure

Summary

This session will provide you with 90-day outcomes of a novel no-implant interatrial shunt first in human trial, six-month outcomes of transcatheter LV restoration in heart failure patients, and mid-term results of hybrid LV reconstruction in ischemic HFrEF.

Presentations available when logged in:

  • 90 day outcomes of a novel no-implant interatrial shunt first in human trial
  • Transcatheter LV restoration in heart failure patients : 6-months outcome
  • Update on mid-term results of hybrid LV reconstruction in ischemic HFrEF